Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Collaborative cOMMUNIty Care for Metastatic breAsT cancEr Patients in inDonesia (Communicated)
- Status
- NOT_YET_RECRUITING
- Phase
- NA
The COMPASSION Study
- Status
- RECRUITING
- Phase
- NA
STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid (AVATAR)
- Status
- RECRUITING
- Phase
- NA
Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests.
- Status
- RECRUITING
- Phase
- PHASE2
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)
- Status
- RECRUITING
- Phase
- PHASE2
Prevalence of Emerging Treatment-induced Mutations in Metastatic ER-positive Breast Cancer.
- Status
- RECRUITING
- Phase
- N/A
HER-2 B Cell Peptide Vaccine
- Status
- RECRUITING
- Phase
- PHASE1
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- NA
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada
- Status
- COMPLETED
- Phase
- N/A
A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Status
- RECRUITING
- Phase
- PHASE3
HER2 Targeted Molecular Imaging in mBC Using 68Ga-ABS011
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
The FEMA Study: Feasibility of Exercise in Patients With Metastatic Breast Cancer and Adiposity
- Status
- COMPLETED
- Phase
- NA
A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- N/A